ANDREWS; MARK DAVID
Patent Applications and Registrations
Patent applications and USPTO patent grants for ANDREWS; MARK DAVID.The latest application filed is for "n-acylpiperidine ether tropomyosin-related kinase inhibitors".
- ANDREWS; MARK DAVID - SANDWICH KENT
- Andrews; Mark David - Kent GB
- Andrews; Mark David - Sandwidh GB
- Andrews, Mark David - County of Kent GB
| Patent | Date |
|---|---|
| N-acylpiperidine Ether Tropomyosin-related Kinase Inhibitors App 20170305857 - SKERRATT; SARAH ELIZABETH ; et al. | 2017-10-26 |
| Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors Grant 9,163,021 - Andrews , et al. October 20, 2 | 2015-10-20 |
| Tropomyosin-Related Kinase Inhibitors App 20150250785 - Andrews; Mark David ; et al. | 2015-09-10 |
| Pyrrolo[3,2-C]Pyridine Tropomyosin-Related Kinase Inhibitors App 20150246912 - Andrews; Mark David ; et al. | 2015-09-03 |
| Pyrrolo[2,3-D]Pyrimidine Tropomyosin-Related Kinase Inhibitors App 20150218172 - Andrews; Mark David ; et al. | 2015-08-06 |
| PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS App 20140364415 - Andrews; Mark David ; et al. | 2014-12-11 |
| Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors Grant 8,846,698 - Andrews , et al. September 30, 2 | 2014-09-30 |
| Diazepine and diazocane compounds as MC4 agonists Grant 8,592,403 - Andrews , et al. November 26, 2 | 2013-11-26 |
| PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS App 20120258950 - Andrews; Mark David ; et al. | 2012-10-11 |
| Melanocortin type 4 receptor agonist piperidinoylpyrrolidines Grant 8,138,188 - Andrews , et al. March 20, 2 | 2012-03-20 |
| Diazepine and Diazocane Compounds As MC4 Agonists App 20110136814 - Andrews; Mark David ; et al. | 2011-06-09 |
| Melanocortin Type 4 Receptor Agonist Piperidinoylpyrrolidines App 20090036459 - Andrews; Mark David ; et al. | 2009-02-05 |
| Novel Compounds App 20080306123 - Fish; Paul Vincent ; et al. | 2008-12-11 |
| Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds App 20080269233 - Andrews; Mark David ; et al. | 2008-10-30 |
| Compounds Grant 7,378,436 - Fish , et al. May 27, 2 | 2008-05-27 |
| Diaryl compounds App 20050026920 - Andrews, Mark David ; et al. | 2005-02-03 |
| Amide derivatives as selective serotonin re-uptake inhibitors App 20050014789 - Andrews, Mark David ; et al. | 2005-01-20 |
| Diaryl compounds Grant 6,800,652 - Andrews , et al. October 5, 2 | 2004-10-05 |
| Diaryl compounds App 20040097509 - Andrews, Mark David ; et al. | 2004-05-20 |
| Phenoxyphenylheterocyclyl derivatives as SSRIs Grant 6,630,504 - Andrews , et al. October 7, 2 | 2003-10-07 |
| Phenoxybenzylamine derivatives as SSRIs Grant 6,610,747 - Adam , et al. August 26, 2 | 2003-08-26 |
| Phenoxybenzylamine derivatives as SSRls App 20030060456 - Adam, Mavis Diane ; et al. | 2003-03-27 |
| Phenoxyphenylheterocyclyl derivatives as SSRIs App 20020183303 - Andrews, Mark David ; et al. | 2002-12-05 |
| Diphenyl ether compounds useful in therapy App 20020052395 - Andrews, Mark David ; et al. | 2002-05-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 